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Abstract
Background: Multiple adverse events are associated with the use of morphine for the treatment of chronic
non-cancer pain, including opioid-induced hyperalgesia (OIH). Mechanisms of OIH are independent of opioid
tolerance and may involve the morphine metabolite morphine-3-glucuronide (M3G). M3G exhibits limited affinity
for opioid receptors and no analgesic effect. Previous reports suggest that M3G can act via the Toll-like receptor 4
(TLR4)/myeloid differentiation protein-2 (MD-2) heterodimer in the central nervous system to elicit pain.
Methods: Immunoblot and immunocytochemistry methods were used to characterize the protein expression of
TLR4 present in lumbar dorsal root ganglion (DRG). Using in vitro intracellular calcium and current clamp
techniques, we determined whether TLR4 activation as elicited by the prototypical agonists of TLR4,
lipopolysaccharide (LPS) and M3G, contributed to changes in intracellular calcium and increased excitation. Rodents
were also injected with M3G to determine the degree to which M3G-induced tactile hyperalgesia could be
diminished using either a small molecule inhibitor of the MD-2/TLR4 complex in rats or TLR4 knockout mice. Whole
cell voltage-clamp recordings were made from small- and medium-diameter DRG neurons (25 μm<DRG diameter
<45 μm) for both control and M3G-treated neurons to determine the potential influence on voltage-gated sodium
channels (NaVs).
Results: We observed that TLR4 immunoreactivity was present in peptidergic and non-peptidergic sensory neurons
in the DRG. Non-neuronal cells in the DRG lacked evidence of TLR4 expression. Approximately 15% of assayed
small- and medium-diameter sensory neurons exhibited a change in intracellular calcium following LPS
administration. Both nociceptive and non-nociceptive neurons were observed to respond, and approximately 40%
of these cells were capsaicin-insensitive. Increased excitability observed in sensory neurons following LPS or M3G
could be eliminated using Compound 15, a small molecule inhibitor of the TLR4/MD-2 complex. Likewise, systemic
injection of M3G induced rapid tactile, but not thermal, nociceptive behavioral changes in the rat, which were
prevented by pre-treating animals with Compound 15. Unlike TLR4 wild-type mice, TLR4 knockout mice did not
exhibit M3G-induced hyperalgesia. As abnormal pain sensitivity is often associated with NaVs, we predicted that
M3G acting via the MD-2/TLR4 complex may affect the density and gating of NaVs in sensory neurons. We show
that M3G increases tetrodotoxin-sensitive and tetrodotoxin-resistant (NaV1.9) current densities.
Conclusions: These outcomes provide evidence that M3G may play a role in OIH via the TLR4/MD-2 heterodimer
complex and biophysical properties of tetrodotoxin-sensitive and tetrodotoxin-resistant NaV currents.
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Introduction
Opioids such as morphine have been and continue to
be used for the treatment of chronic pain. Adverse
events such as opioid-induced hyperalgesia (OIH) often
complicate the clinical course of pain treatment and
may be due to the morphine metabolite morphine-3-
glucuronide (M3G). Morphine is metabolized primarily
in the mammalian liver into two metabolites, M3G and
morphine-6-glucouronide (M6G) via glucuronidation
[1,2]. Approximately 44 to 55% of morphine is converted
to M3G and 9 to 15% to M6G [3,4]. M6G is thought to
be responsible for much of the pain-relieving effects of
morphine by acting on opioid receptors [2,5]. Due to
low affinity for opioid receptors, M3G has effectively no
analgesic effect [6,7]. However, administration of M3G
in rodents elicits myoclonus and stimulus-dependent
hyperalgesia [8,9].
The mechanism or receptor by which M3G induces
these excitatory effects is unknown. However, actions
of M3G in the nervous system are thought to occur
through the Toll-like receptor 4 (TLR4) and the accessory
secreted glycoprotein myeloid differentiation protein-2
(MD-2) complex to elicit proinflammatory glial activation
[9,10]. More importantly, TLR4 knockout mice exhibit a
three-fold leftward shift in the systemic dose of morphine
necessary for analgesia when compared with wild-type
mice [10]. Further evidence to support M3G as a novel
TLR4 agonist is needed - particularly evidence of a di-
rect effect on states of neuronal excitation and/or no-
ciceptive behavior.
Agonist-induced activation of the TLR4/MD-2 com-
plex is not limited to cells of the immune system or glial
cells since the prototypical ligand of TLR4/MD-2 com-
plex, lipopolysaccharide (LPS), can elicit the release of
the neuropeptide calcitonin gene-related peptide (CGRP)
from cultured dorsal root ganglion (DRG) and trigem-
inal root ganglion (TRG) sensory neurons and sensitize
the transient receptor potential cation channel subfamily
V member 1 (TRPV1) [11,12]. Neuronal release of
CGRP is likely due to a combination of LPS-evoked
TRPV1 sensitization and inward ion current changes;
however, it is unknown whether the novel TLR4 agonist
M3G has direct effects on states of neuronal excitation
and/or nociceptive behavior.
The aim of our investigation was to test whether M3G
administration increases sensory neuron excitation and
alters nociceptive behavior in rodents. The M3G-
dependent depolarization of sensory neurons would
imply that there may be a number of ion channels
downstream of TLR4 activation which may contribute
to changes in nociceptive behavior. Using current
clamp and whole-cell voltage-clamp recordings, we found
that M3G increased excitability in small- and medium-
sized acutely dissociated sensory neurons and enhanced
tetrodotoxin-sensitive (TTX-S) and tetrodotoxin-resistant
(TTX-R) voltage-gated sodium channel (NaV) densities
in sensory neurons. We also demonstrated that M3G
acting through the neuronal TLR4/MD-2 complex is
likely responsible for rapid induction of tactile, but not




Pathogen-free, adult female Sprague–Dawley rats (150
to 200 g; Harlan Laboratories, Madison, WI, USA) and
adult male C57BL/10ScNJ and C57BL/6 mice (20 to
25 g; Jackson Laboratory, Bar Harbor, ME, USA) were
used for all experiments. C57BL/10ScNJ mice exhibit a
homozygous deletion of 74 kb at the Tlr4 locus. Mice
and rats were housed in temperature (23 ± 3°C) and light
(12 hour:12 hour light:dark cycle; lights on at 07.00)
controlled rooms with standard rodent chow and water
available ad libitum. These experiments were approved
by the IACUC of Indiana University/Purdue University
in Indianapolis. All procedures were conducted in accor-
dance with the Guide for Care and Use of Laboratory
Animals published by the National Institutes of Health
and the ethical guidelines of the International Association
for the Study of Pain. Animals were randomly assigned to
treatment or control groups.
Drugs
All drugs were freshly prepared in saline on the day of
the experiment and administered by intraperitoneal (i.p.)
injections. A TLR4 small molecule inhibitor (Compound
15) was synthesized as described in detail in [13]. A
stock solution of lipopolysaccharide (LPS) was reconsti-
tuted in sterile 0.1% BSA/PBS to 5 mg/ml, and aliquots
were stored at −20°C (Sigma-Aldrich, St Louis, MO,
USA). The concentration used was 1 μg/mL. Morphine-
3-β-D-glucuronide (M3G) was supplied by NIH/NIDA
Drug Supply Program and utilized at a concentration
(3 μM) that is significantly less than the dose necessary
to elicit responses in rodent central nervous system neu-
rons [14,15].
Tissue processing and immunocytochemistry for neural
tissue
Naïve rat lumbar DRG tissue was collected after animals
were sacrificed and transcardially perfused with Zamboni
fixative. Primary antiserum used for immunocytoche-
mical procedures [16] was anti-TLR4 goat L14 extracel-
lular monoclonal antibody (1:200 dilution; Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA), monoclonal
anti-NeuN, polyclonal anti-CGRP and IB4-FITC (Sigma-
Aldrich). After incubation with primary antibodies,
14 μm thick tissue sections were incubated in secondary
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antibodies (anti-goat made in horse conjugated to CY3,
Jackson ImmunoResearch, West Grove, PA, USA). Posi-
tive control immunocytochemistry staining for TLR4 was
conducted in rat spleen sections. Specific labeling of
white pulp was observed (data not shown).
Cell counts
Images were taken with an intensified charged coupled de-
vice camera (CoolSnap HQ2, Photometrics, Tucson, AZ,
USA coupled to a Nikon microscope (Nikon Eclipse Ti;
Nikon Instruments Inc., Melville, NY, USA) using Nikon
Elements Software (Nikon Instruments Inc.). TLR4 immu-
nopositive cell counts were conducted using Image Pro
Software (Media Cybernetics, Bethesda, MD, USA). TLR4
cell counts were taken from at least eight serial tissue sec-
tions per L5 ganglia (70 μm between sections) and com-
bined to reach the total percentage of neurons.
Tactile behavioral assessment
Von Frey filaments were used to test mechanical sensi-
tivity before and after M3G and/or Compound 15 ad-
ministration. Prior to initial von Frey tactile testing, all
rodents were habituated to testing chambers for at least
2 days. Animals were tested for baseline responses at
least twice before initiation of the injection paradigm
using previously published methods [16]. Briefly, the rat
was placed on a metal mesh floor and covered with a
transparent plastic dome where the animal rested quietly
after an initial few minutes of exploration.
Animals were habituated to this testing apparatus for
15 minutes a day, 2 days prior to pre-injection behav-
ioral testing. Following acclimatization, each filament
was applied to six spots spaced across the glabrous side
of the hind paw; two distinct spots for the distribution
of each nerve branch (saphenous, tibial and sural).
Mechanical stimuli were applied with seven filaments,
each differing in the bending force delivered (10, 20, 40,
60, 80, 100, and 120 mN), but each fitted with a flat tip
and a fixed diameter of 0.2 mm. The force equivalence
of mN to grams is 100 mN=10.197 g. The filaments
were tested in order of ascending force, with each fila-
ment delivered for 1 second in sequence from the 1st to
the 6th spot alternately from one paw to the other. The
interstimulus interval was 10 to 15 seconds. A cutoff
value of 120 mN was used; animals that did not respond
at 120 mN were assigned that value. Stimuli were ap-
plied randomly to left and right hind paws to determine
the stimulus intensity threshold stiffness required to
elicit a paw withdrawal response.
The incidence of foot withdrawal was expressed as a
percentage of six applications of each filament as a func-
tion of force. A Hill equation was fitted to the function
(Origin version 6.0, Microcal Software Northampton, MA
USA) relating the percentage of indentations eliciting a
withdrawal to the force of indentation. From this equa-
tion, the threshold force was obtained and defined as the
force corresponding to a 50% withdrawal rate. Mouse be-
havior was conducted in a similar fashion using a probe
fitted with a flat tip and a fixed diameter of 0.1 mm. How-
ever, mechanical stimuli were applied to only one location
on the glabrous side of the hind paw. All behavioral tes-
ting was performed by laboratory assistants who were
blinded to the experimental conditions and unfamiliar
with the experimental aims.
Thermal behavioral assessment
Thermal hyperalgesia was determined by measuring foot
withdrawal latency and duration of the response to heat
stimulation [16]. Each rat was placed in a box (22 x 12 x
12 cm) containing a smooth glass floor. A heat source
(UgoBasile Plantar™ Analgesia Instrument, Trappe PA,
USA) was focused on a portion of the hind paw, which
is flush against the glass, and a radiant thermal stimulus
was delivered to that site. The stimulus shuts off auto-
matically when the hind paw moves (or after 20 seconds
to prevent tissue damage). The intensity of the heat
stimulus was constant throughout all experiments. A
thermal stimulus was delivered six times to each hind
paw at 5-minute intervals. The value for the response
based on thermal latency and duration of paw with-
drawal was obtained by averaging five of six measure-
ments per animal. The baseline response for right and
left hind paws were tested for 2 days prior to initiation
of the injection paradigm.
Immunoblot methodology
Fresh frozen L3-L6 DRGs and TRGs were homogenized
in modified RIPA buffer with protease/phosphatase inhi-
bitors (USBio, Swampscott, MA, USA). Samples (40 μg/
lane) were resolved by 10% SDS-PAGE and transferred
to a nitrocellulose membrane. After incubation in 10%
non-fat milk blocking solution overnight at 4°C, the
membrane was incubated with primary antisera for
1 hour (anti-TLR4 goat M16; 1:1,000; Santa Cruz Bio-
technology Inc., Santa Cruz, CA, USA). The membrane
was reprobed with a monoclonal anti-β actin (1:10,000;
Sigma-Aldrich). Immunopositive bands were detected
by enhanced chemiluminescence (ThermoScientific,
Rockford Ill, USA) using donkey anti-goat (Santa Cruz
Biotechnology Inc.) or rabbit anti-mouse (Jackson Immu-
noResearch) horseradish peroxidase-conjugated secondary
antibodies.
Preparation of acutely dissociated dorsal root ganglion
neurons
Lumbar DRGs were acutely dissociated using methods
previously described [16]. Briefly, L1-L6 DRGs were
removed from naïve animals. The DRGs were treated
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with collagenase A and collagenase D in HBSS for
20 minutes (1 mg/ml; Roche Applied Science, Indian-
apolis, IN, USA), followed by treatment with papain (30
units/ml, Worthington Biochemical, Lakewood, NJ,
USA) in HBSS containing 0.5 mM EDTA and cysteine at
35°C. The cells were then dissociated via mechanical tri-
turation in culture media containing 1 mg/ml BSA and
trypsin inhibitor (1 mg/ml, Sigma-Aldrich). The culture
media was DMEM, Ham’s F12 mixture, supplemented
with 10% fetal bovine serum, penicillin and streptomycin
(100 μg/ml and 100 U/ml) and N2 (Life Technologies,
Carlsbad CA, USA). The cells were plated on coverslips
coated with poly-L lysine and laminin (1 mg/ml) and
incubated for 2 to 3 hours before additional culture
media was added to the wells. The cells were then
allowed to sit undisturbed for 12 to 15 hours to adhere
at 37°C (with 5% CO2).
Intracellular calcium imaging
Acute dissociation of lumbar DRG and intracellular cal-
cium imaging was performed using methods previously
described [16]. The dissociated DRG cells were loaded
with fura-2 AM (3 μM, Molecular Probes/Invitrogen Cor-
poration, Carlsbad, CA, USA) for 25 minutes at room
temperature in a balanced sterile salt solution (BSS; NaCl
(140 mM), Hepes (10 mM), CaCl2 (2 mM), MgCl2
(1 mM), glucose (10 mM), KCl (5 mM)). The cells were
rinsed with the BSS and mounted onto a chamber that
was placed onto the inverted microscope. Intracellular cal-
cium was measured by digital video microfluorometry
with an intensified CCD camera (CoolSnap HQ2, Photo-
metrics) coupled to a Nikon microscope (Nikon Eclipse
Ti) and Nikon Elements Software. Cells were illuminated
with a Lamda DG-4 175 W xenon lamp (Sutter Instru-
ments, Novato, CA, USA), and the excitation wavelengths
of the fura-2 (340/380 nm) were selected by a filter chan-
ger (Sutter Instruments). Sterile solution was applied to
cells prior to LPS application, and any cells that responded
to buffer alone were not used in LPS responsive counts.
Compounds were applied directly into the coverslip bath-
ing solution. LPS (1 μg/mL) was applied first, after which
capsaicin (3 nM; Sigma-Aldrich), high K+ (50 μM) and
ATP (3 nM) were added. Only calcium imaging traces that
reflected at least a 50% increase over baseline were
included in the analysis. All data were analyzed by two in-
dependent analyzers and only responses that were in
agreement between the two individuals were used in the
responsive cell counts.
Electrophysiology
Sharp-electrode intracellular recordings were obtained
from 4 to 18 hours after acute dissociation of lumbar
DRG as previously described [17]. Coverslips were
transferred to a recording chamber that was mounted
on the stage of an inverted microscope. The chamber
was perfused with 2 mL bath solution containing: NaCl,
120 mM; KCl, 3 mM; CaCl2, 1 mM; MgCl2, 1 mM;
Hepes, 10 mM; glucose, 10 mM; adjusted to pH 7.4
and osmolarity 300 mosM. The recordings were
obtained at room temperature. Electrodes were filled
with 1.0 M KCl (impedance: 40 to 80 MΩ) and posi-
tioned by a micromanipulator (Newport Corporation,
Irvine, CA, USA). A −0.1 nA current injection was used
to bridge-balance the electrode resistance. Prior to elec-
trode impalement, the size of the soma to be recorded
was classified by eye according to its diameter as small
(≤30 μm), medium (31–45 μm) and large (≥45 μm).
Electrophysiological recordings were performed with
continuous current-clamp in bridge mode using an
AxoClamp-2B amplifier, stored digitally via a Digidata
1322A interface, and analyzed offline with pClamp 9
software (Axon Instruments, Union City, CA, USA).
Only neurons with resting membrane potential more
negative than −45 mV were analyzed. Neuronal excit-
ability of small and medium, dissociated DRG sensory
neurons was measured by injecting 1-second current
pulses into the soma every 30 seconds. Current was
adjusted in order to elicit two to four APs per current
injection under baseline conditions. Following three
control current injections, LPS (1 μg/mL recording so-
lution) or M3G (3 μM) was applied to the coverslip
and current injections continued every 30 seconds.
Neuronal excitability was measured as the number of
APs elicited per current pulse before and after addition
of LPS or M3G. An attempt to reverse changes in ex-
citability generated by LPS and M3G was performed
using the TLR4 inhibitor, Compound 15 [13]. Com-
pound 15 (50 μM) was added following two experimen-
tal current pulses in the presence of LPS or M3G in
experiments where these ligands increased neuronal
excitability.
Whole cell voltage-clamp recordings were made from
small- and medium-diameter DRG neurons (25 μm<
DRG diameter <45 μm) for both control and M3G trea-
ted neurons using a HEKA EPC10 amplifier as previ-
ously described [18]. To ensure the fidelity of the
voltage-clamp during data acquisition all recordings
were made using an extracellular bath solution contain-
ing reduced sodium (70 mM). TTX-S current densities
were estimated following post hoc subtraction of the
slow-inactivating TTX-R current [18]. TTX-R current
densities were measured from recordings obtained in the
presence of 500 nM TTX. NaV1.8 currents were esti-
mated from the current elicited from a 150 ms pulse to
0 mV from a holding potential of −100 mV and NaV1.9
currents were estimated as the current remaining during
the last 10% of a 150 ms test pulse to −60 mV from a
holding potential of −100 mV.
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Statistics
GraphPad Software (LaJolla, CA, USA) was used to de-
termine the statistical significance. The statistical signifi-
cance of differences between means was determined by
Student’s t-test or a one-way analysis of variance
(ANOVA) followed by post hoc, pair-wise comparisons
(Bonferroni’s method). Logistic regression was used to
determine differences in the percentages of different
groups of cells.
Results
Toll-like receptor 4 present on sensory neurons
We first investigated the extent to which TLR4 protein
expression is present in lumbar and trigeminal sensory
ganglia (Figure 1A). TLR4 expression present within the
DRG is localized exclusively in sensory neurons and
averages 28 ± 5.6% of total sensory neurons per DRG
assayed (1 L5 DRG per animal; n = 6 rodents). TLR4-
immunopositive sensory neurons exhibit peptidergic and
non-peptidergic neuronal phenotypes in the rat lumbar
DRG (Figure 1B-M).
Lipopolysaccharide elicits intracellular calcium
mobilization in dissociated sensory neurons
Acute dissociation of DRG cells does not appear to alter
the neuronal expression of TLR4 (Figure 2A). To func-
tionally characterize neuronal TLR4 signaling we moni-
tored intracellular calcium mobilization [Ca2+]i following
acute LPS administration (Figure 2B). The resultant cel-
lular responses were categorized into three neuronal and
non-neuronal cell types: non-capsaicin-sensitive neurons
(high K and ATP responsive), capsaicin-sensitive neu-
rons (capsaicin, high K, and ATP responsive), and glia
(ATP responsive only). A moderate number of sensory
neurons (approximately 14%) exhibited an LPS-induced
[Ca2+]i flux, of which 8.3% were capsaicin-sensitive
(n = 85)and 5.9% were non-capsaicin-sensitive (n = 72).
Likewise, LPS-responsive non-neuronal cells were lim-
ited in number (6.8%, n = 44) (Table 1).
Lipopolysaccharide and morphine-3-glucuronide-induced
sensory neuron excitation can be blocked by Toll-like
receptor 4/myeloid differentiation protein-2 small
molecule inhibitor
LPS has been shown to elicit an inward current in tri-
geminal sensory neurons [12] and enhance sensory
neuron excitability in colonic nociceptive neurons [19].
Based on these observations, agonists of TLR4 should
conceivably increase the excitability of sensory neurons
in response to repeated current injection of the same
amplitude. To determine the degree to which LPS-
induced intracellular calcium mobilization reflects
changes in sensory neuron excitation, we examined
neuronal response using sharp electrodes in current
clamp mode. Following repeated current pulse combined
with LPS administration, we observed a significant in-
crease in the excitability of small- to medium-diameter
sensory neurons when compared to baseline levels
(15.8% neurons responded, 3.2 ± 0.3 action potentials
(APs) for control vs. 11.7 ± 1.7 APs for LPS, n = 38)
(Figure 3). Representative recordings (Figure 3A) and
grouped data (Figure 3B) demonstrate that the excit-
ability of these neurons was significantly increased by
LPS when compared with control levels. We utilized a
previously reported small molecule inhibitor, Com-
pound 15 [13,20], as a chemical probe to further in-
vestigate the molecular mechanism of M3G-induced
neuron response. The ability of Compound 15 to dis-
rupt the TLR4/MD-2 complex formation and select-
ively block TLR4 signal transduction without affecting
other homologous TLR family proteins has been previ-
ously demonstrated [13]. Further, Compound 15 was
screened against a panel of 12 representative kinases,
showing negligible non-specific inhibitory effects [20].
Importantly, Compound 15 demonstrated high specifi-
city and low toxicity both in vitro and in vivo [21],
providing an excellent probing tool to study the TLR4-
specific signal transduction. The specificity of this
compound was utilized in our studies. Additionally,
Compound 15 completely blocked the increased excit-
ability of LPS suggesting that the observed increase in
excitation is mediated through TLR4/MD-2 (100%,
4.5 ± 0.5 APs for LPS +Compound 15, n = 4; ANOVA,
interaction F(2,18) = 21.29, P < 0.0001; Bonferroni mul-
tiple comparison test, *P < 0.05) (Figure 3A,B).
Given the ability of LPS to elicit increased excitability
when combined with a depolarizing current injection in
small- and medium-diameter sensory neurons, we tested
whether M3G could produce similar effects in sensory
neurons. The combination of repeated current pulse
combined with M3G administration significantly
increased the excitability of small- to medium-diameter
sensory neurons when compared to baseline levels
(19.6% neurons responded, 2.8 ± 0.7 APs for control vs.
14.2 ± 2.4 APs for M3G, n = 46) (Figure 3C). Subsequent
treatment with the TLR4/MD-2 small molecule inhibitor
Compound 15 completely blocked M3G-dependent ex-
citability in sensory neurons (100%, 2.0 ± 0.6 APs for
M3G+Compound 15, n = 4; ANOVA, interaction F
(2,22) = 24.16, P < 0.0001; Bonferroni multiple compari-
son test, P < 0.05) (Figure 3C,D).
Pretreatment of rodents with Toll-like receptor 4/myeloid
differentiation protein-2 small molecule inhibitor
prevents the rapid induction of tactile hyperalgesia due
to systemic morphine-3-glucuronide administration
Direct administration of M3G into the central nervous
system by intracerebroventricular or intrathecal routes
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Figure 1 (See legend on next page.)
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produces a range of behaviors, including reductions
in tail flick latencies, touch-evoked agitation and ther-
mal hyperalgesia [8-10,22]. However, there is limited
information regarding the effects of systemic M3G
administration on noxious thermal or tactile stimulus-
dependent behavioral outcomes. Though M3G (10 mg/
kg, i.p.) failed to elicit changes in thermal latencies or
duration (data not shown, n = 4; Student’s t-test, P > 0.05
for both), M3G produced significant reductions in the
paw withdrawal threshold to tactile stimulus (Figure 4A;
n = 6, P < 0.05). In contrast, paw withdrawal threshold
to tactile stimulus in rodents pretreated with Com-
pound 15 (10 mg/kg, i.p., 1 hour), a small molecule
inhibitor of TLR4/MD-2 complex, prior to M3G ad-
ministration (10 mg/kg, i.p.) did not differ from base-
line thresholds or the combination of Compound 15
and vehicle (Figure 4A; n = 6, ANOVA, interaction F
(3,20) = 69.33, P < 0.05; Bonferroni multiple comparison
test, P < 0.05).
Toll-like receptor 4 knockout fails to exhibit morphine-3-
glucuronide-induced tactile hyperalgesia
To define whether M3G is dependent on the presence
of a functional TLR4/MD-2 complex, we tested the
degree to which M3G induces tactile hyperalgesia in a
mouse line that exhibits a spontaneous mutation of
the Tlr4 gene [23]. Like rats treated with M3G, the
Tlr4 wild-type mice displayed a significant increase in
tactile hyperalgesia (Figure 4B; n = 6, t-test, t = 71.55,
df = 10, P < 0.05). However, Tlr4 knockout mice failed
to display tactile hyperalgesia following M3G adminis-
tration (Figure 4B; n = 6, t-test, t = 0.278, df = 10,
P > 0.05).
Morphine-3-glucuronide increases sodium current density
in both tetrodotoxin-sensitive and tetrodotoxin-resistant
sodium currents
TTX-S and TTX-R sodium currents have been shown
to contribute to neuronal excitability in peripheral sen-
sory neurons [24,25]. Here, we tested the possibility
that TTX-S currents (Figure 5A) and TTX-R currents
(NaV1.8 and NaV1.9; Figure 5B) could potentially be
modulated by M3G and thus contribute to the
increased hyperexcitability of sensory neurons in the
presence of M3G. We compared untreated DRG neu-
rons to neurons exposed acutely (approximately 5 min-
utes) to 3 μM M3G. We determined that TTX-S
current density is increased approximately 2.5 times
(Figure 5C, n = 12, P < 0.05) in the presence of M3G,
and persistent TTX-R (NaV1.9) current density is
increased approximately five times (Figure 5E, n = 12,
(See figure on previous page.)
Figure 1 Toll-like receptor 4 expression in sensory neurons. (A) Western blot analysis of Toll-like receptor 4 (TLR4) isolated from trigeminal
root ganglion (TRG) and lumbar L3-L6 dorsal root ganglion (DRG) lysates. (B-M) Immunofluorescent images of TLR4 in peptidergic and non-
peptidergic DRG populations from sectioned naïve L4 or L5 DRGs. NeuN is a neuronal marker (B, green arrowheads), which co-labeled with TLR4
(C, red arrowheads). Nuclei are stained with DAPI (D, H, L, blue). Merged images demonstrate co-labeling of NeuN containing neurons with TLR4
(E, yellow arrowheads). Calcitonin gene-related peptide (CGRP) is a marker for peptidergic-containing sensory neurons (F, green arrowheads),
which co-labeled with TLR4 (G, red arrowheads). Merged images demonstrate co-labeling of CGRP-containing neurons with TLR4 (I, yellow
arrowheads). Isolectin B4 (IB4) is a marker for non-peptidergic sensory neurons (J, green arrowheads), which co-labeled with TLR4 (K, red
arrowheads). Merged images show co-labeling of IB4 non-peptidergic sensory neurons with TLR4 (M, yellow arrowheads). Scale bar is 60 μm
(B-M).
Figure 2 Calcium imaging of functional Toll-like receptor 4
signaling in cultured dorsal root ganglion neurons. (A) Toll-like
receptor 4 (TLR4)-IR (green) is largely restricted to neurons and not
non-neuronal cell types (blue, DAPI) in dissociated dorsal root
ganglion (DRG) cultures. (B) Representative recording of a transient
intracellular calcium increase in a dissociated DRG sensory neuron
via lipopolysaccharide (LPS) administration (1 μg/mL).
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P < 0.05) in the presence of M3G (P < 0.05). In con-
trast, NaV1.8 TTX-R current density is not affected by
M3G (Figure 5D, n = 12, P > 0.05).
Discussion
The production of the M3G metabolite following glucur-
onidation of morphine contributes to many off-target
side effects of the opioid, including pain. Our results
provide the first demonstration that M3G directly
evokes sensory neuron excitability. The receptor respon-
sible for this neuroexcitatory event appears to be the
pattern recognition receptor, TLR4, as we have shown
that treating sensory neurons with an inhibitor of the
TLR4/MD-2 interaction, Compound 15, completely
blocks the increased neuronal excitability evoked by
M3G and effectively prevents systemic M3G-induced
changes in tactile hyperalgesia. More importantly,
whole-cell voltage-clamp recordings demonstrated that
M3G increased TTX-S and TTX-R NaV densities in sen-
sory neurons.
Little is known about the manner in which TLR4 con-
tributes to pain. Broadly speaking, increased spinal
microglial TLR4 activation correlates with both onset of
behavioral hypersensitivity in rodent models of neur-
opathy and following administration of opioids [21,26].
However, the degree to which activation of TLR4
present on sensory neurons contributes to pain behavior
is unknown. Clearly the ability of LPS administration
to elicit intracellular calcium mobilization in both
capsaicin- and non-capsaicin-sensitive neurons suggests
that local administration of LPS to the plantar hind
Table 1 LPS response profile of acutely dissociated DRG
cells from rats
Non-capsaicin-sensitive neuron 6% (5/85)
Capsaicin-sensitive neuron 8% (6/72)
Glia 7% (3/44)
Figure 3 Lipopolysaccharide and morphine-3-glucuronide increase the excitability of nociceptive dorsal root ganglion neurons. Current
clamp recordings were performed on small (≥30 μm) to medium (≥40 μm) dorsal root ganglion (DRG) neurons (L1-6) from naïve rats. Firing of
two to four action potentials (APs) was elicited by a 1 second depolarizing current injection (ranging from 0.1 to 0.6 nA depending on the cell)
every 30 seconds. (A) Representative recordings demonstrating that application of 2 μg/mL lipopolysaccharide (LPS) increases the number of
elicited APs and Compound 15 can reverse this effect. (B) Group data demonstrating that LPS caused a significant increase in DRG AP firing that
is reversed with Compound 15. (C) Representative recordings demonstrating that application of 3 μM morphine-3-glucuronide (M3G) increases
the number of elicited APs and Compound 15 can reverse this effect. (D) Group data showing that M3G caused a significant increase in DRG AP
firing that is reversed by Compound 15.
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paw might produce thermal and mechanical sensitiv-
ities [27,28]. Likewise, the fact that M3G elicits neur-
onal excitation in both small- and medium-diameter
sensory neurons might predict similar thermal- and
tactile-dependent behavioral outcomes. Despite these
expectations, systemic M3G administration evoked be-
havioral changes that were limited only to TLR4/MD-
2-dependent mechanical sensitivities. This outcome
suggests that short-term M3G exposure-mediated
changes in tactile-mediated nociceptive behavior through
TLR4 are independent of inflammation.
The apparent effects of M3G via TLR4/MD-2-mediated
changes in tactile-dependent nociceptive behavior and
non-capsaicin responsive cells may require unique ionic
mechanisms such as modulation of voltage-gated sodium
and/or potassium currents in addition to voltage-de-
pendent calcium channels [29]. Here, we demonstrate
that M3G increased TTX-S currents approximately 2.5
times. The TTX-S current in small-diameter neurons is
most likely a combination of NaV1.6 and Nav1.7 [25].
These TTX-S channels can directly contribute to neuronal
excitability [25], with NaV1.6 attributing to the resurgent
sodium current and NaV1.7 attributing to amplifying sub-
threshold generator potentials by producing a prominent
ramp current [30-32]. Interestingly, the LPS-induced acti-
vation of microglia appears to be dependent on TTX-S
NaV1.6 channels [33].
The TTX-R sodium channel NaV1.9 has been shown
to contribute to the genesis of heat and mechanical pain
hypersensitivity [34]. In addition, NaV1.9 knockout mice
have been shown to lack acute visceral hypersensitivity
[35]. Given the five-fold increase in NaV1.9 current
density, the action of M3G on this sodium channel iso-
form may be critical in the ability of M3G to generate
hyperexcitability in sensory neurons. Supporting evi-
dence includes observations that NaV1.9 enhances and
prolongs the response to depolarizations that are sub-
threshold for AP electrogenesis [36]. NaV1.9 also func-
tions to lower threshold for single AP and repetitive
firing [37]. Thus, NaV1.9 may serve as an anion channel
target for reducing M3G-induced pain sensitivity asso-
ciated with morphine administration. Moreover, the abil-
ity of TLR4 signaling to modulate sodium channels
elucidates a novel mechanism by which TLR4 agonists
can influence neuronal states of excitation.
Mechanisms of excitation in primary sensory neurons
via the TLR4/MD-2 complex remain elusive. However,
due to the fact that IL-1β is known to increase the excit-
ability of nociceptors via enhancing persistent TTX-R
current [38,39], and IL-1β receptors signal through a
common Toll/IL-1 receptor domain [40], it may come
as no surprise that TLR4/MD-2 complex activation is
capable of exciting neurons. Many other possible
mechanisms exist which may also contribute to M3G-
elicited neuronal excitation. It is possible that, in
capsaicin-sensitive sensory neurons, LPS as a surrogate
for M3G induces transactivation of TRPV1 via phospho-
lipase C and results in the production of inositol 1,4,5-
Figure 4 Systemic morphine-3-glucuronide administration fails
to elicit tactile hyperalgesia in rats pretreated with the small
molecule inhibitor of Toll-like receptor 4/myeloid
differentiation protein-2 complex, Compound 15, or in Toll-like
receptor 4 knockout mice. (A) Systemic morphine-3-glucuronide
(M3G) (10 mg/kg, intraperitoneally) produced robust tactile
hyperalgesia (n = 6, ANOVA, Bonferroni multiple comparison test,
*P< 0.05), which could be prevented by pretreatment with
Compound 15 (10 mg/kg, intraperitoneally, n = 6). (B) Shown is the
force necessary to elicit paw withdrawal in Toll-like receptor 4 (Tlr4)
wild-type and Tlr4 knockout mice. Systemic M3G (25 mg/kg,
intraperitoneally) produced robust tactile hyperalgesia in Tlr4 wild-
type mice (n = 6, *P< 0.05). Tlr4 knockout mice failed to display a
decrease in paw withdrawal force following systemic M3G (n = 6).
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triphosphage and subsequent [Ca2+]i release cascade
[41,42]. Subsequently, the increase in LPS-induced [Ca2
+]i may depend on calcium influx via PKA (N-type cal-
cium channels) or PKC pathways (non-N-type calcium
channels) [12,19,43]. However, non-capsaicin-responsive
cells would require other ionic mechanisms, such as
modulation of voltage-gated sodium and/or potassium
currents in addition to voltage-dependent calcium chan-
nels [29].
That the systemic M3G-induced behavioral outcome
observed by our studies was limited to mechanical pain
sensitivity may reflect unique capabilities of a TLR4/
MD-2 dependent, capsaicin-insensitive sensory neuron
population. Few experimental studies exist that delineate
such a population with the exception of a subpopulation
of unmyelinated polymodal nociceptive sensory neurons
that express Mas-related G protein-coupled receptor
member D (Mrgprd). Mrgprd appears to be selectively
expressed in non-peptidergic nociceptors which when
genetically ablated in the adult animal fail to respond to
noxious mechanosensation whereas thermosensation is
unaffected [44,45]. Whether the TLR4 agonist M3G is
dependent on Mrgprd-positive sensory neurons for the
changes in mechanical nociceptive behavior is unknown.
Another subpopulation of sensory neurons that may be
responsive to the administration of M3G is the non-
peptidergic primary afferents that exhibit the delta opi-
oid receptor and functionally contribute to mechanical
pain [46].
In conclusion, TLR4 signaling via M3G within sensory
neurons may provide a critical element for understand-
ing the development of tolerance and paradoxical hyper-
algesia that can occur following morphine-based
therapies. The relationship between TLR4 expression in
DRGs, tactile hyperalgesia and neuronal hyperexcitability
via the morphine metabolite M3G may imply that
TLR4-sensitized neurons may serve a vital signal to
dampen the analgesic effects of morphine. Better under-
standing of these TLR4-mediated events in sensory neu-
rons may provide the necessary framework for the
design of agents that not only counteract deleterious
opioid-induced cellular adaptations but also effectively
reduce analgesic tolerance.
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